Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy
15:55 EST 4 Dec 2012 | Nature Publishing
Patients with colorectal cancer with mutated PIK3CA, identified from two large observational cohorts, had increased cancer-specific and overall survival if they used aspirin regularly after diagnosis compared to non-users. No effect of aspirin was se..
Original Article: Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy
More From BioPortfolio on "Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
